Inhibikase To Start Testing Its Parkinson's Candidate In Patients
July 26, 2021 at 10:09 AM EDT
TheFDA has signed offInhibikase Therapeutics Inc's(NASDAQ: IKT) Phase 1b extension study to evaluate its lead ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.